MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
22.18
+2.89 (14.98%)
Dec 6, 2024, 4:00 PM EST - Market closed
MBX Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Dec '24 Dec 6, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 741 | - | - |
| Enterprise Value | 464 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 |
| Quick Ratio | 25.45 | 20.60 | 12.42 |
| Current Ratio | 25.75 | 21.26 | 12.89 |
| Return on Equity (ROE) | - | -53.75% | - |
| Return on Assets (ROA) | - | -34.14% | - |
| Return on Capital (ROIC) | - | -36.19% | - |
| Buyback Yield / Dilution | -71.70% | -52.73% | - |
| Total Shareholder Return | -71.70% | -52.73% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.